Genetically Modified T Cells Treating Malignant Tumors
NCT06515626
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
BIOLOGICAL:
CAR-T cell reinfusion
Sponsor
Yi Zhang